Aspen placed to spark African M&A charge
The African M&A market received a jolt this week after South African drugs firm Aspen Pharma launched a $2bn new money loan on Monday. Bankers away from the leads are already claiming the facility will be a huge success, capable of encouraging chief executives to consider inorganic growth within the continent after a year of suppressed M&A activity.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
